Venturis
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10455 Markison Rd, Dallas, Texas, 75238,...Phone Number
(972) 681-9368Website
www.venturistherapeutics.comRevenue
$6.3 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Venturis
Venturis Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing novel therapeutics for diseases such as diabetic wounds, severe ischemic heart disease, and peripheral artery disease. Their pipeline includes pre-clinical programs targeting erectile dysfunction, infarct stroke, degenerative disk disease, and Parkinson's Disease. The company specializes in the targeted delivery of next-generation molecules aimed at improving the quality of life for individuals suffering from vascular dysfunction. Venturis Therapeutics employs human proteins from the Fibroblast Growth Factor family to stimulate the growth of new blood vessels in ischemic organs and tissues.Explore more
Venturis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Venturis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Venturis recently announced quarterly report
Check if Venturis has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Venturis has new funding data
Check out if Venturis is spiking on competitors!
Click to see if Venturis had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Venturis
Venturis, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Venturis launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Venturis
Find 3 more new buyers
Compare Similar Companies to Venturis
Compare insights from companies similar to Venturis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Venturis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Venturis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Venturis.
Venturis Tech Stack
A closer look at the technologies used by Venturis
Venturis News & Media
CardioVascular BioTherapeutics, Inc. Appoints Dr. David M. Ornitz and Dr. Arnold I. Chin to its Scientific and Medical Advisory Board
DALLAS, Aug. 31, 2018 /PRNewswire/ -- CardioVascular BioTherapeutics, Inc. ("CVBT," the "Company"). CVBT is pleased to announce the appointments of David M. Ornitz, MD, PhD and Dr. Arnold I. Chin, MD, PhD. "Bringing notable medical researchers such as Drs. Ornitz and Chin will help...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Venturis
Sign Up For FreeTo access detailed company insights
Venturis Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing novel therapeutics for diseases such as diabetic wounds, severe ischemic heart disease, and peripheral artery disease. Their pipeline includes pre-clinical programs targeting erectile dysfunction, infarct stroke, degenerative disk disease, and Parkinson'... Read More
